Search Results

Site Search

MCL Congenital Neutropenia Bone Marrow Failure Telomere Defects and Pulmonary Fibrosis IPF Patient Information MC1235303

MCL Congenital Neutropenia Bone Marrow Failure Telomere Defects Pulmonary Fibrosis IPF Patient Information Complete print Reset Form Congenital Neutropenia Bone Marrow Failure Telomere Defects Pulmonary Fibrosis IPF Patient Information...

Mayo Clinic Laboratory and Pathology Research Roundup: January 16 - Insights

This week's research roundup feature: Understanding the incidence, causes, and trends of sudden cardiac death (SCD) among young competitive athletes is critical to inform preventive policies.

BioPharma Diagnostics - Insights

BioPharma Diagnostics bring Mayo Clinic quality and expertise to collaborative engagements with biopharma, diagnostic and biotech companies to support a range of services, including clinical trial development, assay development, research...

Testing for Streptococcus pneumoniae Antibodies - Insights

In this month's "Hot Topic," Melissa Snyder, Ph.D., identifies the clinical application of testing for Streptococcus pneumoniae polysaccharide antibodies and describes the tests available for measuring these antibodies.

New tests launched in October - Insights

In October 2022, Mayo Clinic Laboratories announced thirty new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

Opioid - Insights

Mayo Clinic Laboratories’ targeted testing for opioids uses high-resolution mass spectrometry to detect 33 different opioids.

Pediatric CNS Disorder Evaluations [Test in Focus] - Insights

Autoimmune encephalitis and myelitis is increasingly recognized as a cause of CNS disease in children and teens. Andrew McKeon, M.B., B.Ch., M.D, gives an overview of this test available through Mayo Clinic Laboratories. He discusses when...

Inborn errors of metabolism - Insights

Learn more about how Mayo Clinic Laboratories’ comprehensive menu of biochemical and molecular testing can diagnose inborn errors of metabolism.

Labile Copper Test Enhances Evaluation for Wilson's Disease: Joshua Bornhorst, Ph.D. - Insights

Joshua Bornhorst, Ph.D., explains how Mayo Clinic Laboratories' labile copper assay (Mayo ID: LBCS) improves upon standard blood tests for Wilson's disease. The new assay measures not just overall copper but also the fraction of copper that...

Specimen Collection and Preparation - Mayo Clinic Laboratories

Instructions by Specimen Type For instructions about collecting and preparing your specimen, you need to identify and select your specimen type:...

fabry_disease_testing_algorithm.pdf

© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. 06/2024 Fabry Disease Diagnostic Testing Algorithm FMTT / Familial Variant, Targeted Testing, Varies Clinical suspicion or family history of Fabry...

Driving change in women's health testing through pioneering research and novel testing strategies - Insights

New diagnostic tests specifically for conditions that predominantly or only affect women, such as autoimmune diseases and gynecological cancers, are empowering female patients and their physicians to make informed decisions.

Biologic Therapies: Reflexive Approaches to Optimizing Treatment for IBD - Insights

Many patients may have flare-ups of their disease, or they may stop responding to treatment. In these situations, the clinician may choose to increase the dose administered or recommend more frequent injections. One cause of decreased...

hereditary_hemochromatosis_algorithm.pdf

11/2024© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. Phlebotomy Phlebotomy Liver biopsy histology and hepatic iron concentration (FET / Iron, Liver Tissue) consistent with HH? Follow...

Prostate Health Index (phi) [Test in Focus] - Insights

Useful For Assessing the patient’s probability of having detectable prostate cancer when totalprostate specific antigen (PSA) concentrations are between

Benzodiazepine - Insights

Mayo Clinic Laboratories’ targeted benzodiazepine testing uses high-resolution mass spectrometry to identify 27 different benzodiazepines and metabolites in the urine.

Controlled substance monitoring - Insights

The Clinical and Forensic Toxicology Laboratory at Mayo Clinic offers the industry’s most comprehensive evidence-based urine drug testing menu to evaluate for the presence of controlled substances.

CPT Codes and LOINC Update: May 2020 - Insights

View a full list of new CPT codes, Test Classification Updates, LOINC Codes, and Z-Codes posted to mayocliniclabs.com during the month of May.

Celiac disease - Insights

While the diagnostic criteria of celiac disease are well defined, symptoms are generally nonspecific. This fact, combined with the variety of available tests — each with a specific utility and interpretation — can make a diagnosis...

April 2023 - Ophthalmic Pathology - Insights

This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Ophthalmic Pathology.

Testing Archives - Insights

Skip to Content MayoACCESS MayoLINK Register My Dashboard...

Key performance indicators for laboratory outreach programs - Insights

Key performance indicators (KPIs) should be a part of every laboratory’s quality improvement plan, and that includes outreach-specific KPI metrics. Financial, internal-facing, and client-facing KPIs for outreach programs help to create a...

Instructions by Specimen Type - Mayo Clinic Laboratories

Test Catalog AlgorithmsDownload Test Catalog & Interpretive HandbookNew TestsNY State Informed Consent TestsPerforming LocationsReferred TestsSpecialty TestingTest Updates...

Novel panel identifies toxins linked to asthma and GI diseases - Insights

Melissa Snyder, Ph.D., explains how Mayo Clinic Laboratories' EDN panel improves the evaluation of certain patients with asthma and autoimmune digestive disorders. EDN is the first laboratory test that provides a marker of...

Pathways Case Studies: June 2022 - Insights

This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for June include the following sub-specialties: Dermatopathology, Gastroenterology...

Specimen Collection and Preparation - Mayo Clinic Laboratories

Test Catalog AlgorithmsDownload Test Catalog & Interpretive HandbookNew TestsNY State Informed Consent TestsPerforming LocationsReferred TestsSpecialty TestingTest Updates...

Result interpretations - Insights

Through specimen validity testing and interpretive results reporting, Mayo Clinic Laboratories ensures the accuracy of every test result.

Top Gun Phlebotomy: Pseudohyperkalemia - Insights

In this month’s “Hot Topic,” Brad Karon, M.D., Ph.D., describes how pseudohyperkalemia has many causes, from collection techniques, processing, and even transport. This presentation focuses on the various preanalytic and analytic causes of...

MCL DrMcKeon PAVAL letter MC2775682

MCL DrMcKeon PAVAL letter Dear Colleague partnering Clinic Laboratories autoimmune neurology testing effort offer

pediatric-autoimmune-cns-demyelinating-disease-diagnostic-algorithm.pdf

10/2024© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. Pediatric Autoimmune Central Nervous System Demyelinating Disease Diagnostic Algorithm NEGATIVE PRESENT PRESENT ABSENT ABSENT Diagnosis:...

Myeloproliferative Neoplasm: Morphology, Molecular Updates and Cost-Effective Test Utilization - Insights

The diagnosis of Myeloproliferative Neoplasm (MPN) must include an integrated approach and combine the clinical findings with laboratory results. In our latest “Hot Topic,” Rong He, M.D., discusses the subclassification of MPNs and the use...

New Tests Launched in September - Insights

In September 2017, Mayo Medical Laboratories announced five new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

Pediatric CNS Disorder Testing - Mayo Clinic Laboratories

We offer a first-of-its-kind profile including only the antibodies that are pertinent to pediatric CNS disorders—all in one evaluation.

tay_sachs_and_related_disorders_diagnostic_testing_algorithm.pdf

© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. Hexosaminidase A enzyme activity is indeterminate or indicates carrier for Tay-Sachs disease (TSD) Sandhoff disease excluded MUGS is performed 2...

Light Protection Tests - Mayo Clinic Laboratories

Test Catalog AlgorithmsDownload Test Catalog & Interpretive HandbookNew TestsNY State Informed Consent TestsPerforming LocationsReferred TestsSpecialty TestingTest Updates...

Kidney function - Insights

Find out how our data-driven testing was developed by experts and uses innovative laboratory technology to monitor all stages of kidney disease.

Diagnosis and inflammation monitoring - Insights

Patients with symptoms that arouse clinical suspicion of either inflammatory bowel disease (IBD) or irritable bowel syndrome (IBS) are both common and tough to differentiate.

Thrombotic Microangiopathies (TMA) [Test in Focus] - Insights

Meera Sridharan, M.D., Ph.D., explains Mayo Clinic Labs’ testing approach for atypical hemolytic uremic syndrome (aHUS). The serological complement panel examines nine analytes to gain a thorough understanding of the complement cascade to...

Tests Aid Diagnosis of Cancer-Associated Neurological Disorders: Divyanshu Dubey, M.B.B.S. - Insights

Divyanshu Dubey, M.B.B.S., explains how Mayo Clinic Laboratories' unique PDE10A and TRIM46 tests facilitate the management of central nervous system disorders triggered by cancers. Early diagnosis and treatment are important for managing...

Test for LDL subtype helps manage coronary risk: Vlad Vasile, M.D., Ph.D., and Leslie Donato, Ph.D. - Insights

Patients with elevated LDL or "bad" cholesterol face even greater risk if their levels of small dense LDL cholesterol are also high. Vlad Vasile, M.D., Ph.D., and Leslie Donato, Ph.D., explain how Mayo Clinic Laboratories' sdLDL-c assay...

Communiqué Archives - Page 3 of 4 - Insights

Skip to Content MayoACCESS MayoLINK Register My Dashboard...

August 2023 - Biochemical Genetics - Insights

This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Biochemical Genetics.

April 2023 - Clinical Chemistry - Insights

This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Clinical Chemistry.

search - Mayo Clinic Laboratories

Test Catalog AlgorithmsDownload Test Catalog & Interpretive HandbookNew TestsNY State Informed Consent TestsPerforming LocationsReferred TestsSpecialty TestingTest Updates...

New tests launched in June - Insights

In June 2023, Mayo Clinic Laboratories announced 28 new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

1889: Rochester's First Operating Room #ThrowbackThursday - Insights

When Saint Marys Hospital opened on September 30, 1889, it included the city’s first operating room that wasn’t also someone’s bedroom or office.

Cutting-edge lab work cracks a medical mystery: Kenneth Hobby - Insights

Kenneth Hobby assumed his fever, fatigue, and aching pains in May 2018 were from another bout of malaria. He was on one of his frequent visits to Zambia in southern Africa, where the mosquito-borne parasite is common. But anti-malaria drugs...

CPT codes and LOINC update: March 2021 - Insights

The following list includes updates posted to mayocliniclabs.com during the month of March.

Testing Archives - Page 23 of 26 - Insights

Skip to Content MayoACCESS MayoLINK...

New tests launched in October - Insights

In October 2020, Mayo Clinic Laboratories announced two new tests along with numerous reference value changes, obsolete tests, and algorithm changes.